Continuous infusion of monoclonal antibody-purified factor VIII: Rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIII
- 1 February 1994
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 45 (2), 142-145
- https://doi.org/10.1002/ajh.2830450209
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Lingual Hemorrhage in a Patient with Hemophilia A Complicated by a High Titer InhibitorJournal of Pediatric Hematology/Oncology, 1993
- Innovative use of porcine factor VIII: C for immune tolerance inductionAmerican Journal Of Medicine, 1991
- Continuous infusion of monoclonal antibody‐purified factor VIIIAmerican Journal of Hematology, 1991
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIBlood, 1983
- Fatal Myocardial Necrosis Associated with Prothrombin-Complex–Concentrate Therapy in Hemophilia ANew England Journal of Medicine, 1983
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980
- Measurement of Mild Factor VIII Inhibitors in Bethesda UnitsThrombosis and Haemostasis, 1975